(USPH) US Physicalrapy - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US90337L1089

USPH: Physical, Therapy, Rehabilitation, Injury, Prevention, Services

U.S. Physical Therapy, Inc. is a leading provider of outpatient physical therapy services, operating a network of clinics across the United States. The company's operations are segmented into two main categories: Physical Therapy Operations and Industrial Injury Prevention Services. Through its Physical Therapy Operations segment, the company offers a range of services, including pre- and post-operative care, treatment for orthopedic-related disorders, sports-related injuries, preventative care, and rehabilitation for injured workers and individuals with neurological-related injuries. This comprehensive approach enables patients to receive personalized care and rehabilitation programs tailored to their specific needs.

The company's Industrial Injury Prevention Services segment is designed to help employers reduce workplace injuries and improve employee health. This is achieved through a variety of services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments. These services are delivered by experienced physical therapists and certified athletic trainers, who work closely with clients to develop and implement customized injury prevention and management programs. U.S. Physical Therapy, Inc.'s client base includes Fortune 500 companies, insurers, and their contractors, demonstrating the company's ability to provide high-quality services to a diverse range of organizations.

Founded in 1990 and headquartered in Houston, Texas, U.S. Physical Therapy, Inc. has established itself as a trusted provider of physical therapy services. With a strong commitment to delivering exceptional patient care and preventing workplace injuries, the company has built a reputation for excellence in the healthcare industry. As a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol USPH, U.S. Physical Therapy, Inc. is subject to the highest standards of corporate governance and transparency. The company's website, https://www.usph.com, provides further information on its services, mission, and values. With an ISIN of US90337L1089 and classified under the GICS Sub Industry of Health Care Facilities, U.S. Physical Therapy, Inc. is a common stock that offers investors the opportunity to participate in the growth and development of the healthcare industry.

Additional Sources for USPH Stock

USPH Stock Overview

Market Cap in USD 1,372m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception 1992-05-28

USPH Stock Ratings

Growth 5y -21.3%
Fundamental 3.56%
Dividend 63.5%
Rel. Strength Industry -196
Analysts 4.14/5
Fair Price Momentum 82.14 USD
Fair Price DCF 123.78 USD

USPH Dividends

Dividend Yield 12m 1.95%
Yield on Cost 5y 1.62%
Annual Growth 5y 40.63%
Payout Consistency 92.0%

USPH Growth Ratios

Growth Correlation 3m 17.3%
Growth Correlation 12m -58.8%
Growth Correlation 5y -0.9%
CAGR 5y -3.69%
CAGR/Mean DD 5y -0.13
Sharpe Ratio 12m -0.08
Alpha -37.33
Beta 1.35
Volatility 32.90%
Current Volume 93.7k
Average Volume 20d 88.7k
What is the price of USPH stocks?
As of January 22, 2025, the stock is trading at USD 90.07 with a total of 93,741 shares traded.
Over the past week, the price has changed by +1.54%, over one month by +0.26%, over three months by +8.48% and over the past year by -3.22%.
Is US Physicalrapy a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, US Physicalrapy is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 3.56 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of USPH as of January 2025 is 82.14. This means that USPH is currently overvalued and has a potential downside of -8.8%.
Is USPH a buy, sell or hold?
US Physicalrapy has received a consensus analysts rating of 4.14. Therefor, it is recommend to buy USPH.
  • Strong Buy: 2
  • Buy: 4
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for USPH stock price target?
According to ValueRays Forecast Model, USPH US Physicalrapy will be worth about 91.5 in January 2026. The stock is currently trading at 90.07. This means that the stock has a potential upside of +1.55%.
Issuer Forecast Upside
Wallstreet Target Price 111.3 23.6%
Analysts Target Price 124.8 38.5%
ValueRay Target Price 91.5 1.6%